Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Czech Republic
Summary - Medicinal Products Containing Searlimab, Enfortumab Vertebine, Gemtuzumab Ozogamicin, Glofitamab, Nivolumab And Relatlimab, Panitumumab, Ramucurumab
Deadline - May 19, 2025
GT reference number - 107333541
Product classification - Antineoplastic agents
Address - Czech Republic
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 107333541
Document Type - Tender Notices
Description - Description: The subject of the public contract is continuous supplies of medicinal products containing caught, enfortumab management, gemtuzumab ozogamicin, glofitamab, nivolumab and relatlimab, panitumumab, ramucirumab for 4 years according to the current needs of the client.local title:: Léčivé přípravky s obsahem dostarlimabu, enfortumab vedotinu, gemtuzumab ozogamicinu, glofitamabu, nivolumabu a relatlimabu, panitumumabu, ramucirumabuContract Duration: : 4 YEARContract Type: : Supplylocal description: : Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem dostarlimabu, enfortumab vedotinu, gemtuzumab ozogamicinu, glofitamabu, nivolumabu a rel
Gt Ref Id - 107333541
Deadline - May 19, 2025
Similar Tenders :
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
